PGY1 residency programs build upon Doctor of Pharmacy education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives. Residents who successfully complete PGY1 residency programs will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) residencies.
In addition to patient care experiences commonly encountered in community-based pharmacy settings, the Revelation Pharma - Innovation Compounding PGY1 Community-Based Pharmacy Residency offers additional training opportunities in sterile and nonsterile compounding, clinical research and formulation development, business administration, and pharmacy advocacy. The Revelation Pharma - Innovation Compounding PGY1 Community-Based Pharmacy Residency prepares pharmacist practitioners to serve as highly qualified independent practitioners who are able to:
demonstrate expertise in the field of sterile and nonsterile compounding;
optimize patient outcomes through personalized medication management and utilization of novel formulations to meet individualized needs of patients;
develop, create, implement, and adhere to sophisticated quality assurance programs;
navigate the intricate regulatory landscape surrounding compounding and ensure adherence to guidelines set by the FDA, USP, and PCAB;
identify and implement efficiencies to increase pharmacy productivity while controlling costs; and
serve in managerial roles within community pharmacies.
Learning Experiences
Orientation
Business Administration and Pharmacy Advocacy
Clinical Liaison Consultation Patient Care
Formulation Research and Development
Innovation Compounding Patient Care
Leader Development
Pharmacy Logistics: Manager’s Perspective
Primary Care Patient Care
Quality Assurance, Quality Compliance, and Regulatory Affairs
Research Project
Staffing at Innovation Compounding Pharmacy (four days each month)
Texas Tech University Health Sciences Center Teaching and Learning Curriculum Program with Teaching Certificate
USP 795 and USP 800 Nonsterile Compounding
USP 797 and USP 800 Sterile Compounding
Stipend and Benefits
Stipend: $54,000 for a 52-week appointment term beginning the first week of July
Educational conference stipend: $5,000
Paid time off: 40 hours
Sick time: up to 48 hours
Seven holidays and one floating holiday
Health, dental, vision, life insurance, and supplemental benefits
401K retirement plan
Employee Assistance Program
Travel Assistance Program
Available positions: 2
Eligibility requirements
Graduate of a Doctor of Pharmacy program from an ACPE-accredited school or college of pharmacy
Legal working status in United States to cover the entire period of residency training (We are unable to sponsor visas for residents)
Eligibility for pharmacist licensure in the state of Georgia (Residents shall obtain Georgia Pharmacist Licensure prior to October 31st)
Negative drug testing results
ASHP Program Code: 34812
PhORCAS Code: 315615
Application package (via PhORCAS)
Cover letter
Curriculum vitae
Three letters of recommendation
Pharmacy school transcripts
Informative Webinars
Visit our website (https://innovationcompounding.com/revelation-group-pgy1) to register for one of our webinars:
Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative and quality pharmacy preparations and services through “industry best” patient care and solutions for customers.
Innovation Compounding is a compounding pharmacy that supports over 7,000 prescribers, 80,000+ patients and annually provides 100,000 prescriptions across the nation. We commit to individualized pharmaceutical care through being Relentless in our drive for personalized medicine, Compassionate toward our patients and doctors, as well as being a Wellness Advocate for our patients’ lives and state of wellbeing. Innovation Compounding Pharmacy is part of a network of 503A and 503B compounding pharmacies within the Revelation Pharma Network – which work together as a collective team to serve patients. Revelation Pharma’s Innovation Compounding Pharmacy’s therapeutic areas include allergy immunotherapy, dermatology/cosmeceutical medicine, functional medicine, geriatrics, hospice/long-term care, infectious disease, intravenous/intramuscular nutrition, men’s health, pain management, pediatrics, veterinary, weight management, and women’s health.